JUPITER, Fla. (AP) — JUPITER, Fla. (AP) — Ligand Pharmaceuticals Inc. (LGND) on Tuesday reported a loss of $51.9 million in its second quarter.
On a per-share basis, the Jupiter, Florida-based company said it had a loss of $2.88. Earnings, adjusted for one-time gains and costs, came to $1.40 per share.
The drugmaker posted revenue of $41.5 million in the period.
Ligand expects full-year earnings in the range of $5 to $5.50 per share, with revenue in the range of $140 million to $157 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LGND at https://www.zacks.com/ap/LGND
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
